Multiple papers reported the beneficial effects of combining autonomous DC maturation via CD40L introduction with factors enhancing T cell activation through 4-1BBL (86) and CD70, in combination with caTRL4 (41, 56, 57, 59, 60), respectively, on tumor immunity. The gene discussed is CD40LG; the disease is neoplasm.